Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
15,247
datasets available to search
ShareScore release 0.9.0
Dataset results
15,247 results for “Breast cancer;”
A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)
ClinicalTrials.gov study NCT00262067. IPD Sharing: Not stated. Countries: 22. Publications: 1.
Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT03199885. IPD Sharing: YES. Countries: 2. Publications: 1.
Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
ClinicalTrials.gov study NCT01349322. IPD Sharing: Not stated. Countries: 8. Publications: 0.
Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer
ClinicalTrials.gov study NCT00470704. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer
ClinicalTrials.gov study NCT01091168. IPD Sharing: Not stated. Countries: 14. Publications: 1.
Radiation Therapy During Surgery in Treating Older Women With Invasive Breast Cancer
ClinicalTrials.gov study NCT00182728. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
ClinicalTrials.gov study NCT02115282. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Multicentre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Three Standard of Care Regimens for The Treatment of Triple-Negative Breast Cancer in the Neoadjuvant/Adj
ClinicalTrials.gov study NCT02688803. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
Diabetes Care for Breast Cancer Patients
ClinicalTrials.gov study NCT05565534. IPD Sharing: NO. Countries: 1. Publications: 2.
Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
ClinicalTrials.gov study NCT01872260. IPD Sharing: YES. Countries: 8. Publications: 1.
Study of LEE011 With Fulvestrant and BYL719 or BKM120 in Advanced Breast Cancer
ClinicalTrials.gov study NCT02088684. IPD Sharing: UNDECIDED. Countries: 8. Publications: 1.
A Study of Subcutaneous At Home Administration of Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2-positive (HER2+) Early Breast Cancer (eBC)
ClinicalTrials.gov study NCT01926886. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study of Bevacizumab (Avastin) in Women With HER2 Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT00333775. IPD Sharing: Not stated. Countries: 24. Publications: 1.
A Study of T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast Cancer
ClinicalTrials.gov study NCT04739761. IPD Sharing: YES. Countries: 18. Publications: 1.
A Study Of PF-05280014 Or Trastuzumab Plus Taxotere® And Carboplatin In HER2 Positive Breast Cancer In The Neoadjuvant Setting (REFLECTIONS B327-04)
ClinicalTrials.gov study NCT02187744. IPD Sharing: YES. Countries: 10. Publications: 1.
A Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors and Colorectal, and Breast Cancers
ClinicalTrials.gov study NCT03251378. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-directed Ther
ClinicalTrials.gov study NCT01419197. IPD Sharing: Not stated. Countries: 22. Publications: 3.
Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT00324259. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients
ClinicalTrials.gov study NCT00428922. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer
ClinicalTrials.gov study NCT02492711. IPD Sharing: NO. Countries: 18. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.